Enzene an integrated global CDMO offers services spanning discovery, development and commercial supply. Its patented fully-connected continuous manufacturing (FCCM) platform, EnzeneX™, is validated for commercial biologics supply, and demonstrates significantly increased production yields and reduced costs. Enzene aims to lower mAb production costs below $40/gram by 2025. Visit www.enzene.com.